Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial.

Brucker, Janina; Mayer, Christine; Gebauer, Gerhard; Mallmann, Peter; Belau, Antje Kristina; Schneeweiss, Andreas; Sohn, Christof; Eichbaum, Michael

Brucker, Janina; Mayer, Christine; Gebauer, Gerhard; Mallmann, Peter; Belau, Antje Kristina; Schneeweiss, Andreas; Sohn, Christof; Eichbaum, Michael.

Afiliação

Brucker J; Department of Gynecology and Obstetrics, University of Heidelberg Medical School, D-69120 Heidelberg, Germany.
Mayer C; Department of Gynecology and Obstetrics, University of Heidelberg Medical School, D-69120 Heidelberg, Germany.
Gebauer G; Department of Gynecology and Gynecological Oncology, Marien Hospital Hamburg, D-22087 Hamburg, Germany.
Mallmann P; Department of Gynecology and Obstetrics, University of Cologne Medical School, D-50931 Köln, Germany.
Belau AK; Department of Gynecology and Obstetrics, University of Greifswald Medical School, D-17475 Greifswald, Germany.
Schneeweiss A; National Center for Tumor Diseases, University Hospital Heidelberg, D-69120 Heidelberg, Germany.
Sohn C; Department of Gynecology and Obstetrics, University of Heidelberg Medical School, D-69120 Heidelberg, Germany.
Eichbaum M; Department of Gynecology, St. Marien Hospital Frankfurt, D-60318 Frankfurt, Germany.

Oncol Lett ; 12(2): 1211-1215, 2016 Aug.

Article em En | MEDLINE | ID: mdl-27446420

Palavras-chave

epithelial ovarian cancer; non-pegylated liposomal doxorubicin; platinum-resistant recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google